Quentis Therapeutics Inc.

Venture capital investment in biopharmaceutical companies ticked higher in the first quarter of 2024. In the second quarter, money is flowing into VC investors and funds focused specifically on the li

Biopharmaceutical executives behind Rempex Pharmaceuticals Inc. and Mpex Pharmaceuticals Inc. raised $33m in Series A venture capital to launch Qpex Biopharma , continuing their entrepreneurial l

When asked if it's true that venture capital investors are no longer interested in funding very early-stage life science companies, Venrock Partner Camille Samuels told Biocom's recent Global Life Sci

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging bioph